Starling Medical has filed a notice of an exempt offering of securities to raise $7,300,613.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Starling Medical is raising up to $7,300,613.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Hannah Mckenney played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Starling Medical
At Starling is building a first-of-its-kind at home urology remote patient monitoring platform that seamlessly integrates into anyones bathroom routine. By monitoring changes in urine over time, we aim to bring the hospitalization reduction benefits of remote monitoring to a new range of chronic conditions such as recurrent UTIs, BPH, and chronic kidney disease.
To learn more about Starling Medical, visit http://www.starlingmedical.com/
Starling Medical Linkedin Page: https://www.linkedin.com/company/starling-medical/
Contact:
Hannah Mckenney, Chief Executive Officer
888-599-8927
https://www.linkedin.com/in/hmck96/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.